In Silico Evaluation of Paxlovid’s Pharmacometrics for SARS-CoV-2: A Multiscale Approach

Paxlovid is a promising, orally bioavailable novel drug for SARS-CoV-2 with excellent safety profiles. Our main goal here is to explore the pharmacometric features of this new antiviral. To provide a detailed assessment of Paxlovid, we propose a hybrid multiscale mathematical approach. We demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartha, Ferenc A., Juhász, Nóra, Marzban, Sadegh, Han, Renji, Röst, Gergely
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146265/
https://www.ncbi.nlm.nih.gov/pubmed/35632843
http://dx.doi.org/10.3390/v14051103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146265/
https://www.ncbi.nlm.nih.gov/pubmed/35632843
http://dx.doi.org/10.3390/v14051103

Ejemplares similares